Polymorphonuclear neutrophils from JAK2V617F positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT)-Reference-Cited by-同舟云学术

Polymorphonuclear neutrophils from JAK2V617F positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT)

Published:2011-03 Issue:3 Volume:46 Page:235-238
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Perrin Julien,Ranta Dana,Empereur Fabienne,Vigneron Claude,Feugier Pierre,Lecompte Thomas

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference31 articles.

1. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments;De Stefano;Haematologica,2008

2. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles;Petrides;Blood Cells Mol. Dis.,2006

3. Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status;Finazzi;Haematologica,2007

4. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors;Wolanskyj;Mayo Clin. Proc.,2006

5. Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera;Landolfi;Blood,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges;Seminars in Thrombosis and Hemostasis;2023-04-17

2. Thrombin generation - a potentially useful biomarker of thrombotic risk in Philadelphia-negative myeloproliferative neoplasms;Biomedical Papers;2017-03-27

3. Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma;Thrombosis Research;2015-07

4. Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management;Journal of Thrombosis and Haemostasis;2013-07